Marta Requesens

5PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2026
CD4+ T cell-licensed CD8+ T cells are required for immunotherapy response in MHC-I negative MMRd cancer.

|Aug 29, 2025
Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level.

Koen Brummel, Marta Requesens, Nienke van Rooij

|Sep 03, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens, Koen Brummel, Annegé Vledder

|Jun 15, 2022
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.

Christy Hong, Michael Schubert, Andréa E Tijhuis

|Mar 16, 2022
Extracellular matrix proteins regulate NK cell function in peripheral tissues.

Mark D Bunting, Maulik Vyas, Marta Requesens

Pageof 1

Frequent Collaborators

4 joint publications

Floris Foijer

3 joint publications

Hans W Nijman

3 joint publications

David N Church

3 joint publications

Marco de Bruyn